Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells.

Armstrong K, Robson CN, Leung HY.

Prostate. 2006 Aug 1;66(11):1223-34.


Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha.

Horion J, Gloire G, El Mjiyad N, Quivy V, Vermeulen L, Vanden Berghe W, Haegeman G, Van Lint C, Piette J, Habraken Y.

J Biol Chem. 2007 May 25;282(21):15383-93. Epub 2007 Apr 4.


Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.

Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, Freeman JW.

J Biol Chem. 2005 Mar 18;280(11):10047-54. Epub 2005 Jan 12.


A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.

Hernandez M, Shao Q, Yang XJ, Luh SP, Kandouz M, Batist G, Laird DW, Alaoui-Jamali MA.

Prostate. 2006 Aug 1;66(11):1151-61.


Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.

Law AY, Lai KP, Lui WC, Wan HT, Wong CK.

Exp Cell Res. 2008 Oct 1;314(16):2975-84. doi: 10.1016/j.yexcr.2008.07.002. Epub 2008 Jul 9.


Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression.

Pan L, Lu J, Wang X, Han L, Zhang Y, Han S, Huang B.

Cancer. 2007 Apr 15;109(8):1676-88.


The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.

Katsura T, Iwai S, Ota Y, Shimizu H, Ikuta K, Yura Y.

Cancer Gene Ther. 2009 Mar;16(3):237-45. doi: 10.1038/cgt.2008.81. Epub 2008 Oct 24.


PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells.

Graham TR, Odero-Marah VA, Chung LW, Agrawal KC, Davis R, Abdel-Mageed AB.

Prostate. 2009 Feb 1;69(2):168-80. doi: 10.1002/pros.20870.


Regulation of neuronal nitric oxide synthase exon 1f gene expression by nuclear factor-kappaB acetylation in human neuroblastoma cells.

Li Y, Zhao Y, Li G, Wang J, Li T, Li W, Lu J.

J Neurochem. 2007 Jun;101(5):1194-204. Epub 2007 Jan 23.


Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.

Chiba T, Yokosuka O, Fukai K, Kojima H, Tada M, Arai M, Imazeki F, Saisho H.

Oncology. 2004;66(6):481-91.


Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.

Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Majid S, Igawa M, Dahiya R.

Int J Cancer. 2008 Aug 1;123(3):552-60. doi: 10.1002/ijc.23590. Erratum in: Int J Cancer. 2017 Oct 1;141(7):1492.


Regulation of FGF8 expression by the androgen receptor in human prostate cancer.

Gnanapragasam VJ, Robson CN, Neal DE, Leung HY.

Oncogene. 2002 Aug 1;21(33):5069-80.


Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells.

Batra S, Sahu RP, Kandala PK, Srivastava SK.

Mol Cancer Ther. 2010 Jun;9(6):1596-608. doi: 10.1158/1535-7163.MCT-09-1146. Epub 2010 May 18.


Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells.

Wong CY, Wuriyanghan H, Xie Y, Lin MF, Abel PW, Tu Y.

J Biol Chem. 2011 Jul 22;286(29):25813-22. doi: 10.1074/jbc.M110.211292. Epub 2011 Jun 2.

Supplemental Content

Support Center